[1]
2024. Immunophenotypic Expression and its Association with Prognostic Factors, Clinical Stages, and Clinical Profiles in Newly Diagnosed Patients with Plasma Cell Myeloma: Insights from Two Tertiary Care Centers. Biomedical Research and Therapy. 11, 3 (Mar. 2024), 6248–6261. DOI:https://doi.org/10.15419/bmrat.v11i3.870.